4/A//SEC Filing
CORE LABORATORIES N V 4/A
Accession 0001209191-07-035322
CIK 0001000229operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:59 PM ET
Size
10.5 KB
Accession
0001209191-07-035322
Insider Transaction Report
Form 4/AAmended
DENSON JOHN D
VP, Gen.Counsel, & Secretary
Transactions
- Exercise/Conversion
Common Shares
2005-06-01+11,304→ 69,587 total - Tax Payment
Common Shares
2005-06-01$25.54/sh−11,304$288,704→ 58,283 total - Exercise/Conversion
Tax Offset Right
2002-06-01−11,304→ 0 totalExercise: $0.00From: 2005-06-01Exp: 2005-06-01→ Common Shares (11,304 underlying)
Holdings
- 16,469(indirect: By 401(k))
Common Shares
Footnotes (3)
- [F1]This amendment restates the original Form 4 in its entirety to reflect the deletion of an erroneously reported disposition of shares.
- [F2]The number of shares reported in this column has been reduced by the number of phantom shares issued pursuant to the Core Laboratories, Inc. Deferred Compensation Plan. Those phantom shares entitle the reporting person to receive a cash settlement only and no common shares will be issued.
- [F3]The tax-offset right was granted in connection with the award of restricted shares issued pursuant to an Executive Share Matching Restricted Share Agreement. The tax-offset right entitles the reporting person to receive, upon vesting of the restricted shares, common shares the value of which is equal to the tax obligation incurred in connection with the event, including the tax-offset payment.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:59 PM ET
- Size
- 10.5 KB